In a new study, Lipska et al. genetically screened an unselected cohort of 227 adolescents with steroid-resistant nephrotic syndrome (SRNS). From their findings, the authors make suggestions for what they feel would be the most rational and cost-effective approach for genetic screening in sporadic adolescent SRNS.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Lipska, B. S. et al. Genetic screening in adolescents with steroid-resistant nephrotic syndrome. Kidney Int. http://dx.doi.org/10.1038/ki.2013.93.
Boute, N. et al. NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat. Genet. 24, 349–354 (2000).
Aucella, F. et al. WT1 mutations in nephrotic syndrome revisited. High prevalence in young girls, associations and renal phenotypes. Pediatr. Nephrol. 21, 1393–1398 (2006).
Brown, E. J. et al. Mutations in the formin gene INF2 cause focal segmental glomerulosclerosis. Nat. Genet. 42, 72–76 (2010).
Ruf, R. G. et al. Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. J. Am. Soc. Nephrol. 15, 722–732 (2004).
Gbadegesin, R. A., Winn, M. P. & Smoyer, W. E. Genetic testing in nephrotic syndrome—challenges and opportunities. Nat. Rev. Nephrol. 9, 179–184 (2013).
Mele, C. et al. MYO1E mutations and childhood familial focal segmental glomerulosclerosis. N. Engl. J. Med. 365, 295–306 (2011).
Genovese, G. et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329, 841–845 (2010).
Ozaltin, F. et al. Disruption of PTPRO causes childhood-onset nephrotic syndrome. Am. J. Hum. Genet. 89, 139–147 (2011).
Stefanidis, C. J. & Querfeld, U. The podocyte as a target: cyclosporine A in the management of the nephrotic syndrome caused by WT1 mutations. Eur. J. Pediatr. 170, 1377–1383 (2011).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Mak, R., Smoyer, W. Genetic screening in steroid-resistant nephrotic syndrome. Nat Rev Nephrol 9, 379–381 (2013). https://doi.org/10.1038/nrneph.2013.101
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2013.101
